{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:18:08Z","timestamp":1791764288859,"version":"4.3.4"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T00:00:00Z","timestamp":1700870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"F. Hoffmann-La Roche Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Digital patient monitoring (DPM) tools can facilitate early symptom management for patients with cancer through systematic symptom reporting; however, low adherence can be a challenge. We assessed patient\/healthcare professional (HCP) use of DPM in routine clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>Patients with locally advanced\/metastatic lung cancer or HER2-positive breast cancer received locally approved\/reimbursed drugs alongside DPM, with elements tailored by F. Hoffmann-La Roche Ltd, on the Kaiku Health DPM platform. Patient access to the DPM tool was through their own devices (eg, laptops, PCs, smartphones, or tablets), via either a browser or an app on Apple iOS or Android devices. Coprimary endpoints were patient DPM tool adoption (positive threshold: 60%) and week 1-6 adherence to weekly symptom reporting (positive threshold: 70%). Secondary endpoints included experience and clinical impact.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At data cutoff (June 9, 2022), adoption was 85% and adherence was 76%. Customer satisfaction and effort scores for patients were 76% and 82%, respectively, and 83% and 79% for HCPs. Patients spent approximately 10 minutes using the DPM tool and completed approximately 1.0 symptom questionnaires per week (completion time 1-4 minutes). HCPs spent approximately 1-3 minutes a week using the tool per patient. Median time to HCP review for alerted versus non-alerted symptom questionnaires was 19.6 versus 21.5 hours. Most patients and HCPs felt that the DPM tool covered\/mostly covered symptoms experienced (71% and 75%), was educational (65% and 92%), and improved patient-HCP conversations (70% and 83%) and cancer care (51% and 71%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The DPM tool demonstrated positive adoption, adherence, and user experience for patients with lung\/breast cancer, suggesting that DPM tools may benefit clinical cancer care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/oncolo\/oyad289","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T16:09:26Z","timestamp":1696608566000},"page":"e561-e569","source":"Crossref","is-referenced-by-count":12,"title":["Feasibility and User Experience of Digital Patient Monitoring for Real-World Patients With Lung or Breast Cancer"],"prefix":"10.1093","volume":"29","author":[{"given":"Edurne","family":"Arriola","sequence":"first","affiliation":[{"name":"Medical Oncology Department, Hospital del Mar , Barcelona , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Jaal","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, University of Tartu , Tartu , Estonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Edvardsen","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Akershus University Hospital , L\u00f8renskog , Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Silvoniemi","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Turku University Hospital , Turku , Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f3nio","family":"Ara\u00fajo","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Centro Hospitalar Universit\u00e1rio de Santo Ant\u00f3nio , Porto , Portugal"},{"name":"UMIB - Unit for Multidisciplinary Research in Biomedicine, ICBAS - School of Medicine and Biomedical Sciences, University of Porto , Porto , Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Vikstr\u00f6m","sequence":"additional","affiliation":[{"name":"Pulmonary Clinic, University Hospital , Link\u00f6ping , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Zairi","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, St. Luke\u2019s Hospital , Thessaloniki , Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari Carmen","family":"Rodriguez-Mues","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Hospital Cl\u00ednico Barcelona , Barcelona , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Roccato","sequence":"additional","affiliation":[{"name":"Program Manager Office (PMO), Kaiku Health , Helsinki , Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Schneider","sequence":"additional","affiliation":[{"name":"Pharma Personalised Healthcare, F. Hoffmann-La Roche Ltd , Basel , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4656-0949","authenticated-orcid":false,"given":"Johannes","family":"Ammann","sequence":"additional","affiliation":[{"name":"Global Product Development Medical Affairs, F. Hoffmann-La Roche Ltd , Basel , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,11,25]]},"reference":[{"key":"2024041017280856200_CIT0001","first-page":"715","article-title":"A review of the prevalence and impact of multiple symptoms in oncology patients","volume-title":"J Pain Symptom Manage","author":"Kim","year":"2009"},{"key":"2024041017280856200_CIT0002","first-page":"175","article-title":"Cancer-related symptoms","volume-title":"Semin Radiat Oncol","author":"Cleeland","year":"2000"},{"key":"2024041017280856200_CIT0003","first-page":"1714","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology Clinical Practice Guideline","volume-title":"J Clin Oncol","author":"Brahmer","year":"2018"},{"key":"2024041017280856200_CIT0004","first-page":"107","article-title":"Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study","volume-title":"Support Care Cancer","author":"Hilarius","year":"2012"},{"key":"2024041017280856200_CIT0005","first-page":"151","article-title":"Professional educational needs for chemotherapy-induced nausea and vomiting (CINV): multinational survey results from 2388 health care providers","volume-title":"Support Care Cancer","author":"Van Laar","year":"2015"},{"key":"2024041017280856200_CIT0006","first-page":"733","article-title":"Early palliative care for patients with metastatic non-small-cell lung cancer","volume-title":"N Engl J Med","author":"Temel","year":"2010"},{"key":"2024041017280856200_CIT0007","first-page":"834","article-title":"Effects of early integrated palliative care in patients with lung and GI cancer: a randomized clinical trial","volume-title":"J Clin Oncol","author":"Temel","year":"2017"},{"key":"2024041017280856200_CIT0008","first-page":"929","article-title":"Optimal recall periods for patient-reported outcomes: challenges and potential solutions","volume-title":"Curr Med Res Opin","author":"Stull","year":"2009"},{"key":"2024041017280856200_CIT0009","first-page":"617","article-title":"Comparison of patient and proxy EORTC QLQ-C30 ratings in assessing the quality of life of cancer patients","volume-title":"J Clin Epidemiol","author":"Sneeuw","year":"1998"},{"key":"2024041017280856200_CIT0010","first-page":"6","article-title":"Oncologists\u2019 perception of depressive symptoms in patients with advanced cancer: accuracy and relational correlates","volume-title":"BMC Psychol","author":"Gouveia","year":"2015"},{"key":"2024041017280856200_CIT0011","first-page":"255","article-title":"Evaluation of different recall periods for the US National Cancer Institute\u2019s PRO-CTCAE","volume-title":"Clin Trials","author":"Mendoza","year":"2017"},{"key":"2024041017280856200_CIT0012","first-page":"339","article-title":"The state of cancer care in America, 2016: a report by the American Society of Clinical Oncology","volume-title":"J Oncol Pract","author":"American Society of Clinical Oncology","year":"2016"},{"key":"2024041017280856200_CIT0013","first-page":"o1430","article-title":"Shortages of radiology and oncology staff putting cancer patients at risk, college warns","volume-title":"BMJ","author":"Limb","year":"2022"},{"key":"2024041017280856200_CIT0014","article-title":"Cancer Over Time","author":"International Agency for Research on Cancer (IARC)","year":"2023"},{"key":"2024041017280856200_CIT0015","first-page":"e10875","article-title":"Electronic systems for patients to report and manage side effects of cancer treatment: systematic review","volume-title":"J Med Internet Res","author":"Warrington","year":"2019"},{"key":"2024041017280856200_CIT0016","first-page":"4589","article-title":"Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives","volume-title":"Support Care Cancer","author":"Aapro","year":"2020"},{"key":"2024041017280856200_CIT0017","first-page":"878","article-title":"The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline","volume-title":"Ann Oncol","author":"Di Maio","year":"2022"},{"key":"2024041017280856200_CIT0018","first-page":"573","article-title":"Effects of a computerized system to support shared decision making in symptom management of cancer patients: preliminary results","volume-title":"J Am Med Inform Assoc","author":"Ruland","year":"2003"},{"key":"2024041017280856200_CIT0019","first-page":"557","article-title":"Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial","volume-title":"J Clin Oncol","author":"Basch","year":"2016"},{"key":"2024041017280856200_CIT0020","first-page":"197","article-title":"Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment","volume-title":"JAMA","author":"Basch","year":"2017"},{"key":"2024041017280856200_CIT0021","first-page":"djx029","article-title":"Randomized trial comparing a web-mediated follow-up with routine surveillance in lung cancer patients","volume-title":"J Natl Cancer Inst","author":"Denis","year":"2017"},{"key":"2024041017280856200_CIT0022","first-page":"306","article-title":"Two-year survival comparing web-based symptom monitoring vs routine surveillance following treatment for lung cancer","volume-title":"JAMA","author":"Denis","year":"2019"},{"key":"2024041017280856200_CIT0023","first-page":"85","article-title":"Reduced symptom burden with the support of an interactive app during neoadjuvant chemotherapy for breast cancer - a randomized controlled trial","volume-title":"Breast","author":"Fjell","year":"2020"},{"key":"2024041017280856200_CIT0024","first-page":"1607","article-title":"Chemotherapy-related neuropathic symptom management: a randomized trial of an automated symptom-monitoring system paired with nurse practitioner follow-up","volume-title":"Support Care Cancer","author":"Kolb","year":"2018"},{"key":"2024041017280856200_CIT0025","first-page":"2000","article-title":"Intervention combining nurse navigators (NNs) and a mobile application versus standard of care (SOC) in cancer patients (pts) treated with oral anticancer agents (OAA): results of CapRI, a single-center, randomized phase III trial","volume-title":"J Clin Oncol","author":"Mir","year":"2020"},{"key":"2024041017280856200_CIT0026","first-page":"2083","article-title":"Documentation patterns and impact on observed side effects of the CANKADO ehealth application: an exploratory analysis of the PreCycle trial","volume-title":"J Clin Oncol","author":"Degenhardt","year":"2020"},{"key":"2024041017280856200_CIT0027","first-page":"e18655","article-title":"Digital monitoring and management of patients with advanced or metastatic non-small cell lung cancer treated with cancer immunotherapy and its impact on quality of clinical care: interview and survey study among health care professionals and patients","volume-title":"J Med Internet Res","author":"Schmalz","year":"2020"},{"key":"2024041017280856200_CIT0028","first-page":"1866","article-title":"Psychosocial outcomes of an electronic self-report assessment and self-care intervention for patients with cancer: a randomized controlled trial","volume-title":"Psychooncology","author":"Fann","year":"2017"},{"key":"2024041017280856200_CIT0029","first-page":"e295","article-title":"Comparing effects in regular practice of e-communication and web-based self-management support among breast cancer patients: preliminary results from a randomized controlled trial","volume-title":"J Med Internet Res","author":"B\u00f8r\u00f8sund","year":"2014"},{"key":"2024041017280856200_CIT0030","first-page":"859","article-title":"AMTRA: a multicentered experience of a web-based monitoring and tailored toxicity management system for cancer patients","volume-title":"Support Care Cancer","author":"Rasschaert","year":"2021"},{"key":"2024041017280856200_CIT0031","first-page":"e1303","article-title":"Chemotherapy remote care monitoring program: integration of SMS text patient-reported outcomes in the electronic health record and pharmacist intervention for chemotherapy-induced nausea and vomiting","volume-title":"JCO Oncol Pract","author":"Hough","year":"2021"},{"key":"2024041017280856200_CIT0032","first-page":"7002","article-title":"Phase III randomized controlled trial of eRAPID (electronic patient self-Reporting of Adverse-events: Patient Information and advice)\u2014an eHealth intervention during chemotherapy","volume-title":"J Clin Oncol","author":"Velikova","year":"2020"},{"key":"2024041017280856200_CIT0033","first-page":"12000","article-title":"Randomized trial of remote cancer symptom monitoring during COVID-19: impact on symptoms, QoL, and unplanned health care utilization","volume-title":"J Clin Oncol","author":"Mooney","year":"2021"},{"key":"2024041017280856200_CIT0034","first-page":"199","article-title":"Electronic self-report assessment for cancer and self-care support: results of a multicenter randomized trial","volume-title":"J Clin Oncol","author":"Berry","year":"2014"},{"key":"2024041017280856200_CIT0035","first-page":"n1647","article-title":"Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART)","volume-title":"BMJ","author":"Maguire","year":"2021"},{"key":"2024041017280856200_CIT0036","first-page":"537","article-title":"Automated home monitoring and management of patient-reported symptoms during chemotherapy: results of the symptom care at home RCT","volume-title":"Cancer Med","author":"Mooney","year":"2017"},{"key":"2024041017280856200_CIT0037","first-page":"e14058","article-title":"Electronic patient-reported outcomes (ePROs) and machine learning (ML) in predicting the presence and onset of immune-related adverse events (irAEs) of immune checkpoint inhibitor (ICI) therapies","volume-title":"J Clin Oncol","author":"Iivanainen","year":"2020"},{"key":"2024041017280856200_CIT0038","first-page":"S1057","article-title":"Predicting the onset of immune-related adverse events (irAEs) in immune checkpoint inhibitor (ICI) therapies using a machine learning (ML) model trained with electronic patient-reported outcomes (ePROs) and lab measurements","volume-title":"Ann Oncol","author":"Iivanainen","year":"2020"},{"key":"2024041017280856200_CIT0039","first-page":"S1068","article-title":"A combination model of electronic patient-reported outcomes (ePROs) and lab measurements in prediction of immune related adverse events (irAEs) and treatment response of immune checkpoint inhibitor (ICI) therapies","volume-title":"Ann Oncol","author":"Iivanainen","year":"2020"},{"key":"2024041017280856200_CIT0040","first-page":"21","article-title":"Indicators of retention in remote digital health studies: a cross-study evaluation of 100,000 participants","volume-title":"NPJ Digit Med","author":"Pratap","year":"2020"},{"key":"2024041017280856200_CIT0041","volume-title":"Council directive of 20 June 1990 on the approximation of the laws of the Member States relating to active implantable medical devices","author":"EUR-Lex","year":"2020"},{"key":"2024041017280856200_CIT0042","volume-title":"Regulation (EU) 2020\/561 of the European Parliament and of the Council of 23 April 2020 amending Regulation (EU) 2017\/745 on medical devices, as regards the dates of application of certain of its provisions","author":"EUR-Lex","year":"2020"},{"key":"2024041017280856200_CIT0043","first-page":"101714","article-title":"Development and implementation strategies of a nurse-led symptom self-management program in outpatient cancer centres: the Symptom Navi\u00a9 Programme","volume-title":"Eur J Oncol Nurs","author":"Bana","year":"2020"},{"key":"2024041017280856200_CIT0044","first-page":"e027942","article-title":"Implementation of the Symptom Navi \u00a9 Programme for cancer patients in the Swiss outpatient setting: a study protocol for a cluster randomised pilot study (Symptom Navi\u00a9 Pilot Study)","volume-title":"BMJ Open","author":"Bana","year":"2019"},{"key":"2024041017280856200_CIT0045","first-page":"151","article-title":"Flyer to improve self-management of symptoms for patients with cancer \u2013 evaluation of feasibility and comprehensibility of the Symptom Navi","volume-title":"Pflege","author":"Kropf-Staub","year":"2017"},{"key":"2024041017280856200_CIT0046","first-page":"E687","article-title":"Pilot testing of a nurse-led basic symptom self-management support for patients receiving first-line systemic outpatient anticancer treatment: a cluster-randomized study (Symptom Navi Pilot Study)","volume-title":"Cancer Nurs","author":"Bana","year":"2021"},{"key":"2024041017280856200_CIT0047","first-page":"104","article-title":"Composite grading algorithm for the National Cancer Institute\u2019s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)","volume-title":"Clin Trials","author":"Basch","year":"2021"},{"key":"2024041017280856200_CIT0048","first-page":"6","article-title":"Effects of an internet support system to assist cancer patients in reducing symptom distress: a randomized controlled trial","volume-title":"Cancer Nurs","author":"Ruland","year":"2013"},{"key":"2024041017280856200_CIT0049","first-page":"e12689","article-title":"Utilizing digital health to collect electronic patient-reported outcomes in prostate cancer: single-arm pilot trial","volume-title":"J Med Internet Res","author":"Tran","year":"2020"},{"key":"2024041017280856200_CIT0050","first-page":"973","article-title":"A randomized trial of weekly symptom telemonitoring in advanced lung cancer","volume-title":"J Pain Symptom Manage","author":"Yount","year":"2014"},{"key":"2024041017280856200_CIT0051","first-page":"2163","article-title":"Feasibility of an eHealth application \u201cOncoKompas\u201d to improve personalized survivorship cancer care","volume-title":"Support Care Cancer","author":"Duman-Lubberding","year":"2016"},{"key":"2024041017280856200_CIT0052","first-page":"924","article-title":"\u201cOncokompas,\u201d a web-based self-management application to support patient activation and optimal supportive care: a feasibility study among breast cancer survivors","volume-title":"Acta Oncol","author":"Melissant","year":"2018"},{"key":"2024041017280856200_CIT0053","first-page":"1467","article-title":"Detection of lung cancer relapse using self-reported symptoms transmitted via an internet web-application: pilot study of the sentinel follow-up","volume-title":"Support Care Cancer","author":"Denis","year":"2014"},{"key":"2024041017280856200_CIT0054","first-page":"S1352","article-title":"Patient-reported symptom monitoring improves health-related quality of life in lung cancer patients: the SYMPRO-Lung trial","volume-title":"Ann Oncol","author":"Billingy","year":"2022"},{"key":"2024041017280856200_CIT0055","first-page":"765","article-title":"ePROs in the follow-up of cancer patients treated with immune checkpoint inhibitors: a retrospective study","volume-title":"J Cancer Res Clin Oncol","author":"Iivanainen","year":"2019"},{"key":"2024041017280856200_CIT0056","first-page":"14","article-title":"Impact of a telehealth intervention on quality of life and symptom distress in patients with head and neck cancer","volume-title":"J Community Support Oncol","author":"Pfeifer","year":"2015"},{"key":"2024041017280856200_CIT0057","first-page":"2413","article-title":"Effect of electronic symptom monitoring on patient-reported outcomes among patients with metastatic cancer: a randomized clinical trial","volume-title":"JAMA","author":"Basch","year":"2022"},{"key":"2024041017280856200_CIT0058","first-page":"e063242","article-title":"Assessing the impact of digital patient monitoring on health outcomes and healthcare resource usage in addition to the feasibility of its combination with at-home treatment, in participants receiving systemic anticancer treatment in clinical practice: protocol for an interventional, open-label, multicountry platform study (ORIGAMA)","volume-title":"BMJ Open","author":"Iivanainen","year":"2023"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/29\/4\/e561\/57210423\/oyad289.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/29\/4\/e561\/57210423\/oyad289.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T14:15:35Z","timestamp":1712758535000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/29\/4\/e561\/7451126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,25]]},"references-count":58,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,11,25]]},"published-print":{"date-parts":[[2024,4,4]]}},"URL":"https:\/\/doi.org\/10.1093\/oncolo\/oyad289","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4,1]]},"published":{"date-parts":[[2023,11,25]]}}}